Ashleigh Marie Moore, NP
Nurse Practitioner · Corona
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ashleigh Marie Moore’s office at (951) 737-1454 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$30,681
Medicare paid this office $30,681 for 152 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 101 | $14,080 | $77 |
| New patient visit (60+ min) | 41 | $5,828 | $142 |
| New patient visit (45+ min) | 47 | $4,920 | $105 |
| Long return visit (40+ min) | 15 | $2,019 | $112 |
| Short return visit (20+ min) | 32 | $1,811 | $52 |
See all 7 services
| Return visit (30+ min) | 101 | $14,080 | $77 |
| New patient visit (60+ min) | 41 | $5,828 | $142 |
| New patient visit (45+ min) | 47 | $4,920 | $105 |
| Long return visit (40+ min) | 15 | $2,019 | $112 |
| Short return visit (20+ min) | 32 | $1,811 | $52 |
| New patient visit (30+ min) | 19 | $1,237 | $65 |
| Short return visit | 11 | $335 | $28 |
Who their Medicare patients are
152 Original Medicare patients in 2024. Average age 67 · Under 65 36% · 85 and older 12% · Women 45% · Also on Medicaid 55% · Health risk score 6.78. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 75% · Heart failure 62% · Coronary heart disease 53% · Depression 38% · COPD 34% · Atrial fibrillation 32% · Stroke 20% · Cancer 16% · Dementia 10%.
The office billed $39,167, Medicare allowed $38,507 and paid $30,681; for 368 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$165,357
Pharmacies billed $165,357 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (16 of 1,371) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,121 generic and 217 brand-name prescriptions · $165,357 in drug cost · 84 antibiotic prescriptions to 63 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 24 | $25,736 | $1,072 |
| Mounjaro | 16 | $16,682 | $1,043 |
| Trulicity | 12 | $10,991 | $916 |
| Eliquis | 13 | $8,719 | $671 |
| Lantus Solostar | 11 | $1,322 | $120 |
See all 42 drugs
| Ozempic | 24 | $25,736 | $1,072 |
| Mounjaro | 16 | $16,682 | $1,043 |
| Trulicity | 12 | $10,991 | $916 |
| Eliquis | 13 | $8,719 | $671 |
| Lantus Solostar | 11 | $1,322 | $120 |
| Nano 2nd Gen Pen Needle | 11 | $587 | $53 |
| Losartan | 51 | $584 | $11 |
| Atorvastatin | 88 | $571 | $6 |
| Valsartan | 14 | $501 | $36 |
| Omeprazole | 22 | $412 | $19 |
| Levothyroxine | 44 | $393 | $9 |
| Fluticasone Propionate | 19 | $275 | $14 |
| Amlodipine Besylate | 57 | $259 | $5 |
| Pantoprazole | 17 | $239 | $14 |
| Albuterol Sulfate Hfa | 12 | $232 | $19 |
| Gabapentin | 16 | $212 | $13 |
| Metformin | 30 | $206 | $7 |
| Amoxicillin-Clavulanate Potass | 12 | $198 | $16 |
| Potassium Chloride | 14 | $192 | $14 |
| Lisinopril | 29 | $187 | $6 |
| Metoprolol | 26 | $183 | $7 |
| Rosuvastatin | 23 | $174 | $8 |
| Carvedilol | 22 | $128 | $6 |
| Alendronate | 11 | $120 | $11 |
| Hydrochlorothiazide | 31 | $118 | $4 |
| Furosemide | 24 | $118 | $5 |
| Hydralazine | 12 | $114 | $9 |
| Montelukast | 21 | $99 | $5 |
| Simvastatin | 13 | $88 | $7 |
| Glipizide | 15 | $81 | $5 |
| Losartan-Hydrochlorothiazide | 15 | $76 | $5 |
| Metformin Hcl Er | 18 | $72 | $4 |
| Zolpidem | 11 | $72 | $7 |
| Clonidine | 22 | $66 | $3 |
| Doxycycline Hyclate | 13 | $64 | $5 |
| Ciprofloxacin | 16 | $60 | $4 |
| Tramadol | 15 | $60 | $4 |
| Sertraline | 13 | $55 | $4 |
| Metoprolol | 12 | $49 | $4 |
| Levocetirizine Dihydrochloride | 14 | $47 | $3 |
| Prednisone | 16 | $32 | $2 |
| Azithromycin | 13 | $21 | $2 |
Year by year
| 2024 | 1,371 | 260 | 1% (16) | 16% | $165,357 |
| 2023 | 1,598 | 257 | 3% (48) | 14% | $199,056 |
| 2022 | 719 | 161 | 3% (22) | None | $110,718 |
| 2021 | 20 | 14 | 0% (0) | 0% | $272 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 50 drugs
| Trulicity | 27 | $26,929 | $997 |
| Eliquis | 17 | $12,890 | $758 |
| Januvia | 13 | $9,805 | $754 |
| Trelegy Ellipta | 11 | $7,665 | $697 |
| Breo Ellipta | 11 | $4,759 | $433 |
| Flovent Hfa | 11 | $3,266 | $297 |
| Levothyroxine | 77 | $1,351 | $18 |
| Atorvastatin | 68 | $1,100 | $16 |
| Losartan | 64 | $947 | $15 |
| Azelastine | 23 | $741 | $32 |
| Albuterol Sulfate Hfa | 27 | $632 | $23 |
| Fluticasone Propionate | 35 | $526 | $15 |
| Nitrofurantoin | 27 | $495 | $18 |
| Labetalol | 13 | $439 | $34 |
| Levocetirizine Dihydrochloride | 15 | $434 | $29 |
| Metoprolol | 23 | $414 | $18 |
| Tamsulosin | 19 | $402 | $21 |
| Montelukast | 19 | $401 | $21 |
| Pantoprazole | 20 | $397 | $20 |
| Rosuvastatin | 25 | $359 | $14 |
| Amlodipine Besylate | 57 | $347 | $6 |
| Lisinopril | 29 | $319 | $11 |
| Finasteride | 14 | $311 | $22 |
| Metoprolol | 18 | $290 | $16 |
| Metformin | 32 | $265 | $8 |
| Potassium Chloride | 15 | $261 | $17 |
| Promethazine | 17 | $248 | $15 |
| Clopidogrel | 15 | $244 | $16 |
| Doxycycline Hyclate | 26 | $233 | $9 |
| Levetiracetam | 11 | $227 | $21 |
| Alendronate | 16 | $216 | $14 |
| Omeprazole | 16 | $196 | $12 |
| Hydrochlorothiazide | 35 | $174 | $5 |
| Gabapentin | 13 | $166 | $13 |
| Tramadol | 44 | $153 | $3 |
| Losartan-Hydrochlorothiazide | 16 | $146 | $9 |
| Simvastatin | 13 | $142 | $11 |
| Pravastatin | 12 | $130 | $11 |
| Zolpidem | 12 | $124 | $10 |
| Escitalopram | 17 | $113 | $7 |
| Amoxicillin-Clavulanate Potass | 15 | $108 | $7 |
| Furosemide | 22 | $105 | $5 |
| Atenolol | 11 | $104 | $9 |
| Carvedilol | 26 | $96 | $4 |
| Zolpidem Tartrate Er | 11 | $78 | $7 |
| Naproxen | 11 | $72 | $7 |
| Clonidine | 22 | $62 | $3 |
| Azithromycin | 24 | $61 | $3 |
| Glipizide | 12 | $58 | $5 |
| Prednisone | 35 | $45 | $1 |
2022: 21 drugs
| Januvia | 12 | $13,671 | $1,139 |
| Trulicity | 14 | $12,481 | $892 |
| Eliquis | 11 | $8,346 | $759 |
| Levothyroxine | 35 | $584 | $17 |
| Atorvastatin | 19 | $487 | $26 |
| Losartan | 32 | $390 | $12 |
| Doxycycline Monohydrate | 13 | $378 | $29 |
| Albuterol Sulfate Hfa | 11 | $367 | $33 |
| Fluticasone Propionate | 14 | $267 | $19 |
| Amoxicillin-Clavulanate Potass | 16 | $256 | $16 |
| Amlodipine Besylate | 37 | $188 | $5 |
| Gabapentin | 13 | $153 | $12 |
| Pantoprazole | 13 | $140 | $11 |
| Lisinopril | 15 | $124 | $8 |
| Doxycycline Hyclate | 11 | $124 | $11 |
| Methylprednisolone | 14 | $121 | $9 |
| Hydrochlorothiazide | 19 | $118 | $6 |
| Tramadol | 20 | $116 | $6 |
| Furosemide | 19 | $103 | $5 |
| Azithromycin | 13 | $80 | $6 |
| Meloxicam | 16 | $49 | $3 |
Money from drug and device companies
$321 in 2024
| 2024 | 12 | 15 | None | $321 |
| 2023 | 15 | 16 | None | $356 |
| 2022 | 9 | 14 | None | $266 |
| 2021 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $40 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $35 | 2 payments
|
| Medtronic | Intellis Adaptivestim | $33 | 1 payment
|
| Novo Nordisk | Wegovy | $30 | 2 payments
|
| Amgen | Otezla | $27 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $26 | 1 payment
|
See all 15 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2024-06-12 | Breztri | $20 |
| Amgen | Meals · 2024-06-05 | Otezla | $27 |
| Phathom Pharmaceuticals | Meals · 2024-05-23 | Voquezna | $21 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2024-05-14 | Xifaxan | $16 |
| Exact Sciences | Meals · 2024-05-01 | Cologuard Collection Kit | $20 |
| Medtronic | Meals · 2024-04-25 | Intellis Adaptivestim | $33 |
| Novartis Pharmaceuticals | Meals · 2024-04-10 | Leqvio | $26 |
| Lilly USA | Meals · 2024-04-04 | Jardiance | $20 |
| Abbvie | Meals · 2024-03-07 | Ubrelvy | $25 |
| Hologic Sales and Service | Meals · 2024-03-06 | Thinprep 2000 Processor | $24 |
| GlaxoSmithKline | Meals · 2024-02-21 | Arexvy | $22 |
| Novo Nordisk | Meals · 2024-01-31 | Wegovy | $16 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2024-01-28 | Xifaxan | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2024-01-24 | Airsupra | $20 |
| Novo Nordisk | Meals · 2024-01-17 | None | $14 |
See earlier years (2023, 2022, 2021)
2023: $356
| Novo Nordisk | Ozempic | $40 | 2 payments
|
| Inspire Medical Systems | Inspire | $37 | 1 payment
|
| Amgen | Otezla | $32 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $26 | 1 payment
|
| Lilly USA | Mounjaro | $26 | 1 payment
|
| Abbvie | Qulipta | $24 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $24 | 1 payment
|
| Pfizer | Nurtec Odt | $23 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $20 | 1 payment
|
| Antares Pharma | Xyosted | $17 | 1 payment
|
| Hologic Sales and Service | Thinprep 2000 Processor | $16 | 1 payment
|
| Sanofi-Aventis U.S. | Toujeo | $16 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $15 | 1 payment
|
| Tolmar | Jatenzo | $15 | 1 payment
|
2022: $266
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $67 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $39 | 2 payments
|
| Novo Nordisk | Ozempic | $35 | 2 payments
|
| Lilly USA | Emgality | $31 | 2 payments
|
| Abbvie | Ubrelvy | $21 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Pfs | $19 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $19 | 1 payment
|
| Merck Sharp & Dohme | Belsomra | $16 | 1 payment
|
2021: $14
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $14 | 1 payment
|
Professional record
- NPI
- 1598434201
- Licence
- CA 95018319
More record details
- Sole proprietor
- Yes
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306
- NPI first listed
- 2021-09-08
- NPI last updated
- 2026-01-08
- NPI record certified
- 2026-01-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 12966 Euclid St Ste 110, Garden Grove, CA, 92840 · 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306